Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLCF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DLX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCND2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FXR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORAI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TREML3P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBLN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060835 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SMURF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MST1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFAIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATOH8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100509457 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA6L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR4A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIP1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFI30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on